Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Cash Flow Statement
Cash Flow Statement
Mayinglong Pharmaceutical Group Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Cash Taxes Paid |
(146)
|
(150)
|
(152)
|
(174)
|
(167)
|
(156)
|
(165)
|
(148)
|
(164)
|
(179)
|
(199)
|
(173)
|
(150)
|
(184)
|
(189)
|
(181)
|
(183)
|
(174)
|
(224)
|
(257)
|
(239)
|
(193)
|
(192)
|
(198)
|
(209)
|
(223)
|
(212)
|
(231)
|
(234)
|
(212)
|
(252)
|
(235)
|
(250)
|
(289)
|
(304)
|
(288)
|
(274)
|
(308)
|
(296)
|
(301)
|
(333)
|
|
Change in Working Capital |
(488)
|
(474)
|
(469)
|
(477)
|
(498)
|
(519)
|
(536)
|
(524)
|
(521)
|
(507)
|
(506)
|
(532)
|
(506)
|
(523)
|
(538)
|
(551)
|
(587)
|
(613)
|
(606)
|
(658)
|
(674)
|
(705)
|
(730)
|
(706)
|
(731)
|
(733)
|
(671)
|
(656)
|
(733)
|
(902)
|
(995)
|
(1 162)
|
(1 202)
|
(841)
|
(881)
|
(810)
|
(770)
|
(990)
|
(1 011)
|
(994)
|
(926)
|
|
Cash from Operating Activities |
133
N/A
|
130
-2%
|
111
-15%
|
90
-18%
|
119
+32%
|
112
-6%
|
96
-14%
|
197
+104%
|
143
-28%
|
183
+28%
|
211
+16%
|
117
-45%
|
271
+132%
|
240
-12%
|
292
+22%
|
377
+29%
|
314
-17%
|
356
+14%
|
252
-29%
|
185
-26%
|
321
+73%
|
308
-4%
|
385
+25%
|
374
-3%
|
233
-38%
|
492
+111%
|
468
-5%
|
582
+24%
|
687
+18%
|
283
-59%
|
158
-44%
|
55
-65%
|
144
+162%
|
597
+316%
|
580
-3%
|
607
+5%
|
665
+9%
|
342
-49%
|
388
+14%
|
396
+2%
|
162
-59%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(43)
|
(84)
|
(90)
|
(87)
|
(114)
|
(107)
|
(131)
|
(163)
|
(134)
|
(124)
|
(109)
|
(63)
|
(89)
|
(65)
|
(52)
|
(56)
|
(46)
|
(42)
|
(37)
|
(44)
|
(32)
|
(25)
|
(30)
|
(30)
|
(43)
|
(46)
|
(43)
|
(39)
|
(37)
|
(45)
|
(66)
|
(68)
|
(62)
|
(65)
|
(58)
|
(60)
|
(64)
|
(75)
|
(102)
|
(126)
|
(148)
|
|
Other Items |
29
|
(6)
|
(34)
|
(22)
|
(23)
|
(94)
|
(110)
|
(276)
|
(364)
|
(137)
|
(196)
|
26
|
1
|
(222)
|
(129)
|
(259)
|
(142)
|
164
|
(8)
|
137
|
112
|
(39)
|
123
|
267
|
(206)
|
33
|
(97)
|
(363)
|
73
|
315
|
(235)
|
503
|
(40)
|
2
|
247
|
27
|
(202)
|
(544)
|
(226)
|
(845)
|
46
|
|
Cash from Investing Activities |
(14)
N/A
|
(90)
-534%
|
(124)
-37%
|
(109)
+12%
|
(137)
-26%
|
(201)
-46%
|
(241)
-20%
|
(439)
-82%
|
(498)
-13%
|
(261)
+48%
|
(305)
-17%
|
(37)
+88%
|
(88)
-139%
|
(287)
-227%
|
(181)
+37%
|
(315)
-74%
|
(188)
+40%
|
122
N/A
|
(45)
N/A
|
93
N/A
|
79
-15%
|
(64)
N/A
|
94
N/A
|
237
+153%
|
(249)
N/A
|
(14)
+95%
|
(140)
-920%
|
(401)
-187%
|
36
N/A
|
270
+641%
|
(301)
N/A
|
435
N/A
|
(102)
N/A
|
(63)
+38%
|
189
N/A
|
(33)
N/A
|
(266)
-705%
|
(619)
-132%
|
(328)
+47%
|
(971)
-196%
|
(103)
+89%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Issuance of Debt |
25
|
(4)
|
(98)
|
(1)
|
(14)
|
28
|
64
|
46
|
39
|
13
|
(24)
|
(8)
|
(12)
|
53
|
45
|
43
|
43
|
(4)
|
4
|
7
|
7
|
7
|
12
|
11
|
19
|
15
|
5
|
113
|
107
|
85
|
0
|
(71)
|
(64)
|
(45)
|
(45)
|
(44)
|
397
|
400
|
375
|
425
|
(42)
|
|
Cash Paid for Dividends |
(50)
|
(55)
|
(54)
|
(54)
|
(58)
|
(62)
|
(62)
|
(63)
|
(34)
|
(18)
|
(18)
|
(17)
|
(68)
|
(91)
|
(90)
|
(90)
|
(84)
|
(88)
|
(88)
|
(90)
|
(104)
|
(101)
|
(102)
|
(101)
|
(76)
|
(67)
|
(68)
|
(72)
|
(129)
|
(116)
|
(116)
|
(112)
|
(132)
|
(124)
|
(130)
|
(131)
|
(160)
|
(165)
|
(160)
|
(163)
|
(165)
|
|
Other |
4
|
6
|
9
|
12
|
12
|
7
|
7
|
15
|
15
|
24
|
0
|
15
|
11
|
8
|
0
|
0
|
10
|
3
|
0
|
0
|
11
|
3
|
0
|
(7)
|
(9)
|
(1)
|
0
|
20
|
9
|
19
|
18
|
33
|
33
|
(0)
|
(8)
|
(53)
|
(71)
|
(57)
|
(52)
|
(37)
|
(24)
|
|
Cash from Financing Activities |
(21)
N/A
|
(52)
-151%
|
(143)
-173%
|
(43)
+70%
|
(60)
-40%
|
(28)
+53%
|
9
N/A
|
(2)
N/A
|
20
N/A
|
20
-1%
|
(19)
N/A
|
(10)
+48%
|
(69)
-587%
|
(30)
+57%
|
(38)
-26%
|
(44)
-17%
|
(31)
+29%
|
(89)
-185%
|
(80)
+9%
|
(79)
+2%
|
(86)
-8%
|
(92)
-7%
|
(87)
+5%
|
(97)
-11%
|
(65)
+33%
|
(53)
+18%
|
(64)
-20%
|
61
N/A
|
(13)
N/A
|
(12)
+10%
|
(8)
+32%
|
(149)
-1 791%
|
(162)
-8%
|
(170)
-5%
|
(183)
-8%
|
(228)
-24%
|
166
N/A
|
178
+8%
|
162
-9%
|
225
+39%
|
(231)
N/A
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
(0)
|
(2)
|
(2)
|
(1)
|
(0)
|
3
|
5
|
3
|
3
|
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
1
|
1
|
|
Net Change in Cash |
98
N/A
|
(13)
N/A
|
(156)
-1 125%
|
(61)
+61%
|
(78)
-28%
|
(117)
-50%
|
(137)
-16%
|
(244)
-79%
|
(334)
-37%
|
(56)
+83%
|
(111)
-98%
|
72
N/A
|
116
+61%
|
(76)
N/A
|
74
N/A
|
19
-75%
|
95
+407%
|
388
+309%
|
125
-68%
|
198
+59%
|
315
+59%
|
155
-51%
|
396
+155%
|
517
+31%
|
(78)
N/A
|
423
N/A
|
261
-38%
|
239
-8%
|
709
+196%
|
540
-24%
|
(152)
N/A
|
339
N/A
|
(122)
N/A
|
364
N/A
|
586
+61%
|
346
-41%
|
563
+63%
|
(97)
N/A
|
224
N/A
|
(349)
N/A
|
(170)
+51%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
90
N/A
|
46
-48%
|
21
-55%
|
4
-82%
|
5
+18%
|
5
+7%
|
(35)
N/A
|
34
N/A
|
9
-75%
|
59
+586%
|
103
+74%
|
54
-48%
|
182
+240%
|
174
-4%
|
239
+37%
|
321
+34%
|
268
-17%
|
314
+17%
|
215
-32%
|
142
-34%
|
289
+104%
|
283
-2%
|
355
+25%
|
344
-3%
|
190
-45%
|
445
+134%
|
425
-5%
|
543
+28%
|
651
+20%
|
238
-63%
|
92
-61%
|
(13)
N/A
|
81
N/A
|
532
+555%
|
522
-2%
|
547
+5%
|
600
+10%
|
267
-56%
|
286
+7%
|
270
-5%
|
14
-95%
|